GeoPolitics Pulse

The Heartbeat of World events

Adjuvant Immunotherapy in High-Risk Muscle-Invasive Urothelial Cancer – UroToday​

by ·

Adjuvant Immunotherapy in High-Risk Muscle-Invasive Urothelial Cancer: An Updated Meta-Analysis of Randomized Controlled Trials – Beyond the Abstract. 

​Read More

Related posts:

  1. Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of …​
  2. ChatGPT in Clinical Medicine, Urology and Academia: A Review. – UroToday
  3. Enfortumab vedotin plus pembrolizumab approved in Japan for urothelial carcinoma
  4. Novel Tool for Predicting Response to Immunotherapy in Melanoma Under Study
  5. Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy …